Mabion S.A. | Income Statement

Fiscal year is January-December. All values PLN Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5.80
830.00
2,733.00
-
-
10,662
Cost of Goods Sold (COGS) incl. D&A
1,076.90
4,221.00
5,638.00
6,939.00
8,045.00
10,662
Gross Income
1,071.10
3,391.00
2,905.00
6,939.00
8,045.00
10,662
SG&A Expense
3,166.80
1,395.00
41,688.00
50,673.00
56,008.00
54,658
EBIT
4,249.90
4,813.00
-
56,026.00
64,579.00
66,483
Non Operating Income/Expense
164.80
183.00
237.00
400.00
8,604.00
2,847
Interest Expense
11.10
7.00
235.00
225.00
1,943.00
2,449
Pretax Income
3,878.10
4,454.00
42,541.00
55,826.00
57,887.00
68,870
Income Tax
13.00
7.00
-
-
-
-
Consolidated Net Income
3,891.20
4,461.00
42,541.00
55,826.00
57,887.00
68,870
Net Income
3,891.20
4,461.00
42,541.00
55,826.00
57,887.00
68,870
Net Income After Extraordinaries
3,891.20
4,461.00
42,541.00
55,826.00
57,887.00
68,870
Net Income Available to Common
3,891.20
4,461.00
42,541.00
55,826.00
57,887.00
68,870
EPS (Basic)
0.49
0.48
3.91
4.78
4.91
5.26
Basic Shares Outstanding
7,930.00
9,230.00
10,878.00
11,682.00
11,800.00
13,089.30
EPS (Diluted)
0.49
0.48
3.91
4.78
4.91
5.26
Diluted Shares Outstanding
7,930.00
9,230.00
10,878.00
11,682.00
11,800.00
13,089.30
EBITDA
3,178.90
3,677.00
37,439.00
49,087.00
56,534.00
55,821
Other Operating Expense
12.10
27.00
2,495.00
1,586.00
526.00
1,163
Non-Operating Interest Income
218.10
183.00
29.00
25.00
31.00
915

About Mabion

View Profile
Address
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki LD 95
Poland
Employees -
Website http://www.mabion.eu
Updated 07/08/2019
Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology.